Joan Merrill, MD, explained the study's efficacy and safety outcomes and looks forward to phase 3 trials ahead.
Joan Merrill, MD
Advertisement
Articles by Joan Merrill, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Digital Twins in Dermatology: Your Patient’s Virtual Double Is Coming
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Quality of Life in CSU Shaped by More Than Skin Symptoms
5